Education
About Us
Working with TipRanks
Follow Us
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
Earnings Data
Report Date
May 19, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.4Last Year’s EPS
-1.63Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 31, 2025
|% Change Since: 0.00%
|Next Earnings Date:May 19, 2025
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook for Vivos Therapeutics, highlighting significant revenue growth, strategic market expansion, and successful business model pivot. Despite some challenges with decreased VIP enrollment revenue and ongoing cash flow needs, the overall sentiment is optimistic due to strong financial backing and regulatory advancements.Company Guidance
During the 2024 fiscal year, Vivos Therapeutics reported a 26% increase in product revenue, reaching $7.9 million, while reducing operating expenses by 21%, leading to a 35% reduction in operating loss. The company sold 16,182 oral appliance arches, nearly doubling their sales compared to 2023. Additionally, Vivos expanded into the Middle East, gaining regulatory approvals in several regions and exceeding sales forecasts. The company raised approximately $17.9 million through equity transactions, including a $7.5 million investment from New Seneca Partners. Vivos also launched a new marketing and distribution strategy with Rebis Healthcare, focusing on profit-sharing alliances and acquisitions of sleep testing clinics, projecting roughly $38 million in annual revenue per 1,000 newly diagnosed OSA patients. The company expects significant growth in 2025, driven by their new strategic model, which has shown a 70% conversion rate of OSA patients choosing Vivos treatments, with average revenues of $4,500 per case and contribution margins up to 50%.Revenue Increase and Cost Reduction
In 2024, Vivos Therapeutics increased product revenue by 26% and reduced operating expenses by 21%, resulting in a 35% reduction in operating loss.
Successful Market Expansion
Vivos expanded into the Middle East, gaining regulatory approvals and access to key markets including Dubai, UAE, Jordan, Bahrain, Lebanon, and Qatar. Demand in the region exceeded forecasts.
Strategic Shift in Business Model
Vivos pivoted its business model to partner with or acquire sleep testing clinics, aiming to be involved in the treatment decision process for OSA patients, which is expected to significantly increase revenue.
FDA Clearance for Severe OSA Treatment
FDA clearance was received for Vivos appliances to treat severe OSA, expanding their treatment capabilities and market credibility.
Significant Financial Backing
Raised approximately $17.9 million through multiple equity transactions, including a $7.5 million investment from New Seneca Partners.
High Conversion Rate in Pilot Programs
Pilot testing showed a 70% conversion rate of OSA patients to Vivos treatments, with an average revenue of $4,500 per case and contribution margins of up to 50%.
---
VVOS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
VVOS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 31, 2025 | $2.85 | $2.63 | -7.72% |
| Nov 14, 2024 | $3.12 | $2.84 | -8.97% |
| Aug 14, 2024 | $2.37 | $2.25 | -5.06% |
| May 14, 2024 | $2.49 | $2.18 | -12.45% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Vivos Therapeutics (VVOS) report earnings?
Vivos Therapeutics (VVOS) is schdueled to report earning on May 19, 2025, TBA Not Confirmed.
What is Vivos Therapeutics (VVOS) earnings time?
Vivos Therapeutics (VVOS) earnings time is at May 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VVOS EPS forecast?
VVOS EPS forecast for the fiscal quarter 2025 (Q1) is -0.4.
---